IBSADERMA

Founded by a group of Swiss biologists in 1945, IBSA – Institut Biochimique SA – has gained unique experience in pharmaceutical research and technology. By focusing on the development of innovations that optimize existing molecules and therapeutic solutions, the company has experienced rapid growth and has also expanded internationally; today, its products are available in more than 80 countries across 5 continents.

IBSA leverages its experience and expertise in the pharmaceutical field to expand its activities and develop medical devices for dermatology, based on hyaluronic acid, thus creating a brand dedicated to dermo-aesthetics: IBSA Derma.

Thanks to its scientific expertise, continuous research, technological development, and a modern production process, IBSA Derma has become one of the leading pharmaceutical companies in the production of hyaluronic acid for dermo-aesthetic applications.

IBSA Derma stands out in this vast market by mastering the entire product life cycle, from the production of raw material by biofermentation to the finished product ready to use in prefilled syringes. IBSA Derma now offers a complete range of products whose production, from research to commercialization, is entirely carried out in Europe (Italy).